Cytokinetics
CYTK
#1977
Rank
$10.48 B
Marketcap
$77.22
Share price
3.22%
Change (1 day)
152.27%
Change (1 year)

Revenue for Cytokinetics (CYTK)

Revenue in 2026 (TTM): $0.10 Billion USD

According to Cytokinetics 's latest financial reports the company's current revenue (TTM ) is $0.10 Billion USD. In 2025 the company made a revenue of $88.03 Million USD an increase over the revenue in the year 2024 that were of $18.47 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytokinetics from 2003 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) $0.10 B20.19%
2025 $88.03 M376.56%
2024 $18.47 M145.34%
2023 $7.53 M-92.04%
2022 $94.58 M34.3%
2021 $70.42 M26.15%
2020 $55.82 M107.79%
2019 $26.86 M-14.71%
2018 $31.5 M135.64%
2017 $13.36 M-87.44%
2016 $0.10 B271.3%
2015 $28.65 M-38.95%
2014 $46.94 M53.16%
2013 $30.64 M305.45%
2012 $7.55 M88.98%
2011 $4 M55.28%
2010 $2.57 M-96.84%
2009 $81.53 M556.5%
2008 $12.42 M-8.82%
2007 $13.62 M335.63%
2006 $3.12 M-64.91%
2005 $8.91 M-33.7%
2004 $13.44 M26.92%
2003 $10.59 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
$37.22 B 35,074.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
$0.54 M-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.26 B 153.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
$0.11 B 9.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
$1.28 B 1,113.57%๐Ÿ‡บ๐Ÿ‡ธ USA